Surfacide’s evidence-based solutions target the reduction of pathogens and other causative agents of infectious diseases in healthcare settings, with a primary focus on the control of "superbugs” such as C. diff, CRE, MRSA, VRE, and acinetobacter.
Teri Kermendy
407 Pilot Ct., Suite 300
Waukesha, WI 53188
262-3096226
tkermendy@surfacidemfg.com
